等待開盤 12-18 09:30:00 美东时间
+1.990
+1.56%
今日重点评级关注:Piper Sandler:维持MeiraGTx Hldgs"超配"评级,目标价从28美元升至30美元;RBC Capital:维持4D Molecular Therapeutics"跑赢大市"评级,目标价从26美元升至32美元
11-12 11:43
今日重点评级关注:Guggenheim:维持InflaRx"买入"评级,目标价从10美元升至22美元;巴克莱:维持Tandem糖尿病护理"超配"评级,目标价从51美元升至55美元
11-11 10:49
JP Morgan analyst Pablo Singzon maintains Palomar Hldgs (NASDAQ:PLMR) with a Overweight and raises the price target from $137 to $145.
11-11 01:28
Palomar Holdings shares are trading higher after the company reported better-th...
11-07 06:19
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
11-06 19:12
BATON ROUGE, La., Oct. 30, 2025 /PRNewswire/ -- BCP, a services and infrastructure-focused private equity management firm, today announced an agreement to sell The Gray Casualty & Surety Com...
10-31 04:20
今日重点评级关注:HC Wainwright & Co.:维持Inventiva"买入"评级,目标价从20美元升至24美元;摩根大通:维持BioMarin Pharmaceutical"超配"评级,目标价从116美元升至119美元
10-10 11:36
JP Morgan analyst Jimmy Bhullar maintains Palomar Hldgs (NASDAQ:PLMR) with a Overweight and lowers the price target from $158 to $137.
10-09 21:48
今日重点评级关注:JMP证券:维持Ocular Therapeutix"跑赢大市"评级,目标价从20美元升至29美元;汇丰银行:上调Banco BBVA Argentina评级至"买入",目标价从21美元下调至17美元
10-02 15:08
Evercore ISI Group analyst David Motemaden maintains Palomar Hldgs (NASDAQ:PLMR) with a In-Line and lowers the price target from $168 to $134.
10-01 23:20